Oral Administration of Fluoxetine Incorporated Liposomal Nanoparticles coated with PEG in Treatment of Chronic Mild stress (CMS) / (Record no. 607719)

000 -LEADER
fixed length control field 02704nam a22001577a 4500
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 610
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Sadiq, Nadia
245 ## - TITLE STATEMENT
Title Oral Administration of Fluoxetine Incorporated Liposomal Nanoparticles coated with PEG in Treatment of Chronic Mild stress (CMS) /
Statement of responsibility, etc. Nadia Sadiq
264 ## - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Islamabad :
Name of producer, publisher, distributor, manufacturer SMME- NUST;
Date of production, publication, distribution, manufacture, or copyright notice 2022.
300 ## - PHYSICAL DESCRIPTION
Extent 55p.
Other physical details Soft Copy
Dimensions 30cm
500 ## - GENERAL NOTE
General note Depression is one of the most increasing psychological mood disorders, depression does not have<br/>some specific physical symptoms, but it negatively affects the person mood, way of living and<br/>thinking chronic mild stress (CMS) is one of its type, depression is affecting more than 300million<br/>people in the world. Shortness of breath, headache, being miserable, stomach disturbance and<br/>physical tensions are some of the common symptoms of depression that is reported according to<br/>National Alliance of Mental Health, Anti-depressant are used for altering the neurotransmitters<br/>those are serotonin, dopamine and norepinephrine that are primarily involved in regulating and<br/>mood alleviating mood. Despite the availability of large number of drugs, many of patients are<br/>resistant to the current mode of treatment that are available now adays. The obstacle that is<br/>significant for the transportation of beneficial therapeutic entities to the nervous system is BBB<br/>that is the blood brain barrier. There are junctions that are present in the endothelial cells of the<br/>blood brain barrier that stop the drugs passage. Now nanoparticles are receiving significant<br/>limelight owing to their small size and efficient brain targeting activity, making them likely to<br/>cross the blood brain barrier while carrying the intact drug molecule otherwise incapable of<br/>permeation. In this study the fluoxetine loaded liposomal nanoparticle coated with PEG were<br/>developed to transport the drug across the BBB to the central nervous system having much greater<br/>efficiency. For testing its delivery, the animal that is mice model of depression is used with the<br/>specific name that is designed in order to induce depression like symptoms in mice. Before and<br/>After treatment great differences between the physical behaviors like Elevated maze, open field<br/>test, force swim test etc and sucrose consumption test were identified and plotted, as liposomes<br/>that having capabilities to carry the anti-depressant drug molecule that is administered through the<br/>Oral route of administration or the better and improved method of treatment.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element MS Biomedical Engineering (BME)
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Supervisor : Dr. Nosheen Fatima Rana
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://10.250.8.41:8080/xmlui/handle/123456789/32264">http://10.250.8.41:8080/xmlui/handle/123456789/32264</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type Thesis
Holdings
Withdrawn status Permanent Location Current Location Shelving location Date acquired Full call number Barcode Koha item type
  School of Mechanical & Manufacturing Engineering (SMME) School of Mechanical & Manufacturing Engineering (SMME) E-Books 02/14/2024 610 SMME-TH-815 Thesis
© 2023 Central Library, National University of Sciences and Technology. All Rights Reserved.